![[dr. bob]](/dr-bob-sm.gif)
Dr. Bob is Robert Hsiung, MD,
bob@dr-bob.orgShown: posts 1 to 4 of 4. This is the beginning of the thread.
Posted by Mishal on December 12, 2007, at 4:49:41
I thought it might be the cholinergic action, but now I have every right to believe dopaminergic action is contributing to this. A sharp visual acuteness, moreover it doesn’t cause any discomfort to eyes at all focusing on the minute objects incessantly.
Another Pro of Trivastal..!!
Posted by Mishal on December 12, 2007, at 6:23:44
In reply to Trivastal: Another tag on. Visual acuity..!, posted by Mishal on December 12, 2007, at 4:49:41
It is sad however U.S misses out most of the finest Servier products. ASFAIK, the only Servier med available in U.S is Aceon (perindopril), but Servier has a wide range of products and most of them are proved unique in their aspects.
For example Diamicron (gliclazide) is a Servier diabetes med which is the only sulfonylurea that is not associated with weight again. Moreover it can be safely administered in obese patients too as a reduction in weight is noted. As a result it is the first line med for diabetes in most parts of the world. Or at least in Middle East, I would say.
Stablon (tianeptine) is a unique antidepressant without sexual, weight gain side effects. Not effective for OCD though, but its anxiolytic effect is comparable to 1.5mg of Alprazolam.
Flavedon MR is a unique anti-angina med that can be used in pregnant women too. Perhaps the only angina med safe in pregnancy.
Hyperium is another cardiovascular med that has shown superior efficacy and tolerability to atenolol and clonidine without signicant side effects.
We know most of Servier meds will never make it to U.S. It might be because Servier offer their products at a very reasonable price hence have their own market all around the globe. They make huge sales in both China and India, a market vaster than U.S by all means.
Finally, Valdoxan (agomelatine) a Servier Antidepressant is waiting for FDA approval. I think Americans should have to be extremely lucky to get their hands to it. Medico-politics is too tiring..
BTW, Nothing sinister here. I don't work for Servier though I wish..
Posted by Phillipa on December 12, 2007, at 12:15:30
In reply to Re: Trivastal + More. U.S Misses Servier Products!, posted by Mishal on December 12, 2007, at 6:23:44
Your last comment brought a smile to my face. So they are that superior lucky you. Phillipa
Posted by dapper on December 17, 2007, at 1:10:45
In reply to Re: Trivastal + More. U.S Misses Servier Products! » Mishal, posted by Phillipa on December 12, 2007, at 12:15:30
Regarding valdoxan not being available in the U.S., I believe Novartis bought the rights to valdoxan and are going through the trials right now, so if approved, it will be in the U.S. market
This is the end of the thread.
Psycho-Babble Medication | Extras | FAQ
Dr. Bob is Robert Hsiung, MD,
bob@dr-bob.org
Script revised: February 4, 2008
URL: http://www.dr-bob.org/cgi-bin/pb/mget.pl
Copyright 2006-17 Robert Hsiung.
Owned and operated by Dr. Bob LLC and not the University of Chicago.